India has capped the prices of 52 more drugs, including painkillers and antibiotics, the pricing authority said in a notice.
The additional drugs join a list of nearly 400 essential medicines that have so far been placed under price control in India, where a majority of the people live on under USD 2 a day and health insurance is scarce.
The new drugs to come under price control include commonly-used antibiotics and painkillers as well as medicines used for treating cancer and skin disorders, a notice on the National Pharmaceutical Pricing Authority (NPPA) website said.
Companies including Lupin , Cadila Healthcare and Merck - the Indian arm of the US firm Merck & Co Inc - are among those selling drugs mentioned in the latest notice, the authority said.
Cadila and Lupin, did not immediately respond to a request for comment. Merck's India unit was not immediately reachable.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.
